37675624|t|Tryptamine: A privileged scaffold for the management of Alzheimer's disease.
37675624|a|Alzheimer's disease (AD) is a chronic and irreversible neurodegenerative disease associated with aging. It is characterized by the progressive loss of memory and other cognitive functions. Although the exact etiology of AD is not well explored, several factors, such as the deposition of amyloid-beta (Abeta) plaques, hyperphosphorylation of tau protein, presence of low levels of acetylcholine, and generation of oxidative stress, are key mediators in the progression of AD. Currently, the clinical treatment options for AD are limited and are based on cholinesterase (ChE) inhibitors (e.g., donepezil, rivastigmine, and galantamine), N-methyl-d-aspartic acid receptor antagonists (e.g., memantine), and the recently approved Abeta modulator (e.g., aducanumab). Tryptamine (2-(1H-indol-3-yl)ethan-1-amine) is a small molecule that contains an indole nucleus and an ethylamine side chain. It is also the active metabolite of tryptophan. It possesses a wide range of biological activities related to neurodegenerative disorders, such as ChE inhibition, Abeta aggregation inhibition, antioxidant effects, monoamine-oxidase inhibition, and neuroprotection. Several tryptamine-based hybrid analogs are currently being investigated as multifunctional agents for the development of novel hybrids for AD treatment. Thus, this review article aims to provide in-depth insights into the research progress and strategies for designing multifunctional agents used in Alzheimer's therapy.
37675624	0	10	Tryptamine	Chemical	MESH:C030820
37675624	56	75	Alzheimer's disease	Disease	MESH:D000544
37675624	77	96	Alzheimer's disease	Disease	MESH:D000544
37675624	98	100	AD	Disease	MESH:D000544
37675624	132	157	neurodegenerative disease	Disease	MESH:D019636
37675624	297	299	AD	Disease	MESH:D000544
37675624	365	377	amyloid-beta	Gene	351
37675624	379	384	Abeta	Gene	351
37675624	419	422	tau	Gene	4137
37675624	458	471	acetylcholine	Chemical	MESH:D000109
37675624	549	551	AD	Disease	MESH:D000544
37675624	599	601	AD	Disease	MESH:D000544
37675624	631	645	cholinesterase	Gene	590
37675624	647	650	ChE	Gene	590
37675624	670	679	donepezil	Chemical	MESH:D000077265
37675624	681	693	rivastigmine	Chemical	MESH:D000068836
37675624	699	710	galantamine	Chemical	MESH:D005702
37675624	766	775	memantine	Chemical	MESH:D008559
37675624	804	809	Abeta	Gene	351
37675624	827	837	aducanumab	Chemical	MESH:C000600266
37675624	840	850	Tryptamine	Chemical	MESH:C030820
37675624	852	882	2-(1H-indol-3-yl)ethan-1-amine	Chemical	MESH:C030820
37675624	921	927	indole	Chemical	MESH:C030374
37675624	943	953	ethylamine	Chemical	MESH:C041564
37675624	1002	1012	tryptophan	Chemical	MESH:D014364
37675624	1076	1103	neurodegenerative disorders	Disease	MESH:D019636
37675624	1113	1116	ChE	Gene	590
37675624	1129	1134	Abeta	Gene	351
37675624	1239	1249	tryptamine	Chemical	MESH:C030820
37675624	1371	1373	AD	Disease	MESH:D000544
37675624	1532	1543	Alzheimer's	Disease	MESH:D000544
37675624	Negative_Correlation	MESH:D005702	MESH:D000544
37675624	Negative_Correlation	MESH:D000068836	MESH:D000544
37675624	Negative_Correlation	MESH:D000068836	590
37675624	Association	MESH:D000544	4137
37675624	Negative_Correlation	MESH:D008559	MESH:D000544
37675624	Association	MESH:D000544	351
37675624	Negative_Correlation	MESH:D000077265	590
37675624	Negative_Correlation	MESH:C030820	590
37675624	Negative_Correlation	MESH:D000077265	MESH:D000544
37675624	Negative_Correlation	MESH:C030820	351
37675624	Negative_Correlation	MESH:D005702	590
37675624	Negative_Correlation	MESH:C000600266	MESH:D000544
37675624	Association	MESH:D000109	MESH:D000544
37675624	Negative_Correlation	MESH:C030820	MESH:D000544
37675624	Association	MESH:C000600266	351

